Intravenous human plasma-derived augmentation therapy in alpha 1-antitrypsin deficiency: from pharmacokinetic analysis to individualizing therapy.

MLA

Zamora, Nuria Padullés, et al. “Intravenous Human Plasma-Derived Augmentation Therapy in Alpha 1-Antitrypsin Deficiency: From Pharmacokinetic Analysis to Individualizing Therapy.” The Annals of Pharmacotherapy, vol. 42, no. 5, May 2008, pp. 640–46. EBSCOhost, https://doi.org/10.1345/aph.1K505.

APA

Zamora, N. P., Pla, R. V., Del Rio, P. G., Margaleff, R. J., Frias, F. R., & Ronsano, J. B. M. (2008). Intravenous human plasma-derived augmentation therapy in alpha 1-antitrypsin deficiency: from pharmacokinetic analysis to individualizing therapy. The Annals of Pharmacotherapy, 42(5), 640–646. https://doi.org/10.1345/aph.1K505

Chicago

Zamora, Nuria Padullés, Rafael Vidal Pla, Pilar Gispert Del Rio, Rosendo Jardi Margaleff, Francisco Rodriguez Frias, and Jose Bruno Montoro Ronsano. 2008. “Intravenous Human Plasma-Derived Augmentation Therapy in Alpha 1-Antitrypsin Deficiency: From Pharmacokinetic Analysis to Individualizing Therapy.” The Annals of Pharmacotherapy 42 (5): 640–46. doi:10.1345/aph.1K505.